Literature DB >> 2153346

Cardiovascular lipid accumulation with Coxsackie B virus infection in mice.

N G Ilbäck1, A Mohammed, J Fohlman, G Friman.   

Abstract

The authors used a myocarditic coxsackievirus B3 infection in Balb/c mice to investigate cardiovascular lipid accumulation and whether a cholesterol-enriched diet influences the development of the myocardial inflammatory reaction. It was found that, seven days after CB3 infection, the accumulation of 14C-cholesterol increased by 75% (P less than 0.001) in the heart and by 92% (P less than 0.001) in the aorta. This infection also caused extensive inflammatory lesions (4.5% of tissue section area) and lipid accumulation in the myocardium seven days after inoculation. Seven weeks on a 1% cholesterol-enriched diet did not affect the myocardial area damaged (3.9%), the lethality, or immune cell activity (T, B, and natural killer [NK] cells). The response pattern of myocardial lymphocyte subpopulations was studied with an immune histochemical staining technique. The number of Mac 2+ (macrophages), class II expressing cells, or the T cytotoxic, suppressor/T helper cell ratio was not changed by the cholesterol diet. The number of class II cells tended to increase (38%) with cholesterol and was positively correlated (P less than 0.001) with the Mac 2 expression regardless of the cholesterol diet. Although moderate diet-induced hypercholesterolemia did not alter host response to viral infection, these results support the idea that virus and immune cells may cooperate and play a role in arterial and myocardial lipid accumulation, possibly acting as initiating factors for atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153346      PMCID: PMC1877460     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

Review 2.  Host factors regulating viral clearance.

Authors:  C J Gauntt; E K Godeny; C W Lutton
Journal:  Pathol Immunopathol Res       Date:  1988

Review 3.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

4.  A simple immunoenzyme batch staining method for the enumeration of peripheral human T lymphocyte subsets.

Authors:  A Karlsson-Parra; U Forsum; L Klareskog; O Sjöberg
Journal:  J Immunol Methods       Date:  1983-11-11       Impact factor: 2.303

5.  Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine Coxsackievirus B3 myocarditis.

Authors:  N G Ilbäck; J Fohlman; S Slorach; G Friman
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

6.  Lipoproteins and the pathogenesis of atherosclerosis.

Authors:  D Steinberg
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

7.  The anti-inflammatory effect of LS 2616 and poly I:C in coxsackievirus B3 induced murine myocarditis.

Authors:  N G Ilbäck; J Fohlman; G Friman
Journal:  Antiviral Res       Date:  1988-11       Impact factor: 5.970

8.  Acute myocarditis. Serologic diagnosis, clinical findings and follow-up.

Authors:  T Vikerfors; A Stjerna; P Olcén; R Malmcrona; L Magnius
Journal:  Acta Med Scand       Date:  1988

9.  A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.

Authors:  A Pierres; P Naquet; A Van Agthoven; F Bekkhoucha; F Denizot; Z Mishal; A M Schmitt-Verhulst; M Pierres
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

10.  The effect of exercise and fasting on the myocardial protein and lipid metabolism in experimental bacterial myocarditis.

Authors:  N G Ilbäck; G Friman; R L Squibb; A J Johnson; D A Balentine; W R Beisel
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1984-07
View more
  7 in total

Review 1.  Microorganisms in the aetiology of atherosclerosis.

Authors:  S A Morré; W Stooker; W K Lagrand; A J van den Brule; H W Niessen
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

2.  Galectin-3 expression in human atherosclerotic lesions.

Authors:  M Nachtigal; Z Al-Assaad; E P Mayer; K Kim; M Monsigny
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 3.  Emerging role of Toll-like receptors in atherosclerosis.

Authors:  Linda K Curtiss; Peter S Tobias
Journal:  J Lipid Res       Date:  2008-11-01       Impact factor: 5.922

4.  Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice.

Authors:  Maurice Nachtigal; Abdul Ghaffar; Eugene P Mayer
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

5.  Sequential changes in serum cytokines reflect viral RNA kinetics in target organs of a coxsackievirus B infection in mice.

Authors:  Magnus Lundgren; Per Ola Darnerud; Jonas Blomberg; Göran Friman; Nils-Gunnar Ilbäck
Journal:  J Clin Immunol       Date:  2009-05-09       Impact factor: 8.317

6.  A novel transport mechanism for MOMP in Chlamydophila pneumoniae and its putative role in immune-therapy.

Authors:  Francis O Atanu; Ernesto Oviedo-Orta; Kimberly A Watson
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

7.  Induction of the Coxsackievirus and Adenovirus Receptor in Macrophages During the Formation of Atherosclerotic Plaques.

Authors:  Azadeh Nilchian; Estelle Plant; Malgorzata M Parniewska; Ana Santiago; Aránzazu Rossignoli; Josefin Skogsberg; Ulf Hedin; Ljubica Matic; Jonas Fuxe
Journal:  J Infect Dis       Date:  2020-11-13       Impact factor: 5.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.